| 000 | 01769 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514015839.0 | ||
| 264 | 0 | _c20020412 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a0001-5555 | ||
| 024 | 7 |
_a10.1080/00015550152572976 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMittag, M | |
| 245 | 0 | 0 |
_aSystemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels. _h[electronic resource] |
| 260 |
_bActa dermato-venereologica _c |
||
| 300 |
_a294-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCell Adhesion Molecules _xblood |
| 650 | 0 | 4 |
_aCytokines _xblood |
| 650 | 0 | 4 |
_aE-Selectin _xblood |
| 650 | 0 | 4 |
_aEndothelial Growth Factors _xblood |
| 650 | 0 | 4 |
_aEndothelin-1 _xblood |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIloprost _xadministration & dosage |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xblood |
| 650 | 0 | 4 |
_aLymphokines _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aRaynaud Disease _xblood |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Cell Adhesion Molecule-1 _xblood |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factors |
| 700 | 1 | _aBeckheinrich, P | |
| 700 | 1 | _aHaustein, U F | |
| 773 | 0 |
_tActa dermato-venereologica _gvol. 81 _gno. 4 _gp. 294-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/00015550152572976 _zAvailable from publisher's website |
| 999 |
_c11634529 _d11634529 |
||